Addiction Medicine Journal Club

Does semaglutide cause people to cut down on smoking?

Hendershot CS, Bremmer MP, Paladino MB, Kostantinis G, Gilmore TA, Sullivan NR, Tow AC, Prince MA, Dermody SS, Jordan R, McKee SA, Fletcher PJ, Claus ED, Klein KR. Once-Weekly Semaglutide in Adults With Daily Cigarette Use: A Randomized Clinical Trial. JAMA Netw Open. 2026 May 1;9(5):e2614898. doi: 10.1001/jamanetworkopen.2026.14898. PMID: 42189538; PMCID: PMC13213524



We also discuss GLP1s for mental health, and BORGs (what are those college students up to!?!).



USA Today: BORGs

JAMA Psychiatry: Glucagon-Like Peptide 1 Receptor Agonists and Mental Health

Nature: Can GLP-1s heal the brain? Obesity drugs get a makeover for addiction and depression

---

This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES.

CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/

---

Original theme music: composed and performed by Benjamin Kennedy

Audio editing: Michael Bonanno

Executive producer: Dr. Patrick Beeman

A podcast from Ars Longa Media

---

This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.



The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.

---

Email: addictionmedicinejournalclub@gmail.com

Facebook: @AddictionMedJC

Facebook Group: Addiction Medicine Journal Club

Instagram: @AddictionMedJC

Threads: @AddictionMedJC

YouTube: addictionmedicinejournalclub

Twitter/X: @AddictionMedJC

---

Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Why do patients choose not to get medical care for an opioid overdose?



Harris SJ, Desai IK, Situ Y, Meyer A, Song M, Shah H, Whaley S, Heidari O, Allen ST, Krawczyk N, Sherman SG, Saloner B. "I didn't want to go through the whole rigmarole": A qualitative exploration of overdose survivor service engagement experiences following nonfatal overdose in seven U.S. states. J Subst Use Addict Treat. 2026 Aug 17;191:210093. doi: 10.1016/j.josat.2026.210093. Epub ahead of print. PMID: 42604668.



We also discuss how tobacco companies are blatantly flouting the FDA’s rules on vapes, and the deadly new opioid cychlorphine.



Journal of Pain Research: Cychlorphine (N-Propionitrile Chlorphine): An Emerging Benzimidazolone Synthetic Opioid and Its Implications for Overdose Recognition and Management

New York Times: A Teen Autopsy Marks the Arrival of a Deadly Drug in San Francisco

Stat: Reynolds is selling fruity new vapes unauthorized by FDA

---

This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES.

CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/

---

Original theme music: composed and performed by Benjamin Kennedy

Audio editing: Michael Bonanno

Executive producer: Dr. Patrick Beeman

A podcast from Ars Longa Media

---

This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.



The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.

---

Email: addictionmedicinejournalclub@gmail.com

Facebook: @AddictionMedJC

Facebook Group: Addiction Medicine Journal Club

Instagram: @AddictionMedJC

Threads: @AddictionMedJC

YouTube: addictionmedicinejournalclub

Twitter/X: @AddictionMedJC

---

Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
Learn more about your ad choices. Visit megaphone.fm/adchoices

How often are patients in MOUD treatment taking extra buprenorphine or methadone?



Moon KJ, Genberg BL, Astemborski J, German D, Kirk GD, Mehta SH, Feder KA. Concurrent Use of Extra-Medical Medication for Opioid Use Disorder Among Adults Prescribed Methadone or Buprenorphine: A Cohort Study of Urban Adults Who Have Injected Drugs. Drug Alcohol Rev. 2026 Jul;45(5):e70204. doi: 10.1111/dar.70204. PMID: 42376697; PMCID: PMC13316725.



We also discuss nicotine as a wellness product, and how the FDA approval process for psychedelic drugs is going.



The conversation: How the pro‑nicotine ‘wellness’ movement rebranded an addictive drug

NEJM: FDA’s New Framework for Psychedelic Drugs

Psychiatric Times: FDA Hearing on Psychedelic Medicine Reveals a Field Divided on the Road to Approval

---

This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES.

CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/

---

Original theme music: composed and performed by Benjamin Kennedy

Audio editing: Michael Bonanno

Executive producer: Dr. Patrick Beeman

A podcast from Ars Longa Media

---

This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.



The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.

---

Email: addictionmedicinejournalclub@gmail.com

Facebook: @AddictionMedJC

Facebook Group: Addiction Medicine Journal Club

Instagram: @AddictionMedJC

Threads: @AddictionMedJC

YouTube: addictionmedicinejournalclub

Twitter/X: @AddictionMedJC

---

Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
Learn more about your ad choices. Visit megaphone.fm/adchoices

We discuss an article about the mental health consequences of teen cannabis use.



Young-Wolff KC, Cortez CA, Alexeeff SE, Silver LD, Pacula RL, Slama NE, Padon AA, Satre DD, Campbell CI, Koshy MT, Does MB, Sterling SA. ⁠Adolescent Cannabis Use and Risk of Psychotic, Bipolar, Depressive, and Anxiety Disorders⁠. JAMA Health Forum. 2026 Feb 6;7(2):e256839. doi: 10.1001/jamahealthforum.2025.6839. PMID: 41719031; PMCID: PMC12924094.



We also discuss a new SAMHSA guide on treating cannabis use disorder, and the lawsuit against META



SAMHSA: ⁠ADDRESSING CANNABIS USE DISORDER IN PRIMARY CARE SETTINGS—A LIFESPAN APPROACH⁠

LA Times: ⁠Is social media addiction real? Law and science collide in blockbuster federal suit⁠

---

This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to ⁠this link⁠ to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit ⁠MI CARES⁠.

CME: ⁠https://micaresed.org/courses/podcast-addiction-medicine-journal-club/⁠

---

Original theme music: ⁠composed and performed by Benjamin Kennedy⁠

Audio editing: Michael Bonanno

Executive producer: ⁠Dr. Patrick Beeman⁠

A podcast from ⁠Ars Longa Media⁠

---

This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.



The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.

---

Email: ⁠addictionmedicinejournalclub@gmail.com⁠

Facebook: ⁠@AddictionMedJC⁠

Facebook Group: ⁠Addiction Medicine Journal Club⁠

Instagram: ⁠@AddictionMedJC⁠

Threads: ⁠@AddictionMedJC⁠

YouTube: ⁠addictionmedicinejournalclub⁠

Twitter/X: ⁠@AddictionMedJC⁠

---

Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.

Learn more about your ad choices. Visit megaphone.fm/adchoices

We discuss an article about the benefits of continuing buprenorphine, methadone, and naltrexone long-term.



Hayes CJ, Raciborski RA, Acharya M, Noor NB, Nunes EV, Winhusen TJ. Evaluating the optimal duration of medication treatment for opioid use disorder. Addiction. 2026 Apr;121(4):922-933. doi: 10.1111/add.70211. Epub 2026 Jan 7. PMID: 41501983; PMCID: PMC12980296.



We also discuss increasing reimbursement for smoking cessation counselling, and VA trials of GLP-1s for alcohol use disorder.



StatNews: Quitting smoking is hard. A Medicare change may push doctors to give more help

Medicare proposed 2027 fee schedule (a little light reading)

To make public comments on the 2027 fee schedule

Military Times: VA launches trial to test GLP-1 medication for alcohol use disorder in veterans

---

This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES.

CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/

---

Original theme music: composed and performed by Benjamin Kennedy

Audio editing: Michael Bonanno

Executive producer: Dr. Patrick Beeman

A podcast from Ars Longa Media

---

This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.



The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.

---

Email: addictionmedicinejournalclub@gmail.com

Facebook: @AddictionMedJC

Facebook Group: Addiction Medicine Journal Club

Instagram: @AddictionMedJC

Threads: @AddictionMedJC

YouTube: addictionmedicinejournalclub

Twitter/X: @AddictionMedJC

---

Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.

Learn more about your ad choices. Visit megaphone.fm/adchoices